GenesisX was approved in Europe and is set to be approved in the US late this year. The new robot is a giant leap forward in accessibility. Stereotaxis should get MAGiC approved in Europe in October.

Stereotaxis' MAGiC catheter received CE Mark approval in Europe, enabling the company to earn an additional $3k per procedure with +80% gross margins. FDA approval of MAGiC is expected by September.

Stereotaxis Robotic Magnetic Navigation System Procedure room equipped with Stereotaxis Robotic Magnetic Navigation (RMN) system for minimally invasive endovascular intervention. Robotic cardiac ...

Stereotaxis announced that it has received European CE Mark approval for its MAGiC™ ablation catheter, marking a significant step in advancing robotic technology in electrophysiology. Designed for ...

(RTTNews) - Stereotaxis, Inc. (STXS), a global leader in surgical robotics for minimally invasive interventions, announced on Monday that it has received European CE Mark approval for its MAGiC ...

ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it ...

Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced that it received European CE Mark approval for the MAGiC ablation catheter.